Seno Medical Technologies raised $14.5 million in an equity round from 28 unnamed investors, according to a regulatory filing.
The San Antonio, Texas-based medical device company is developing opto-acoustic imaging technology to locate cancerous tumors in breast tissue.
The technology uses laser light to slightly heat the tumor, which then emits an acoustic pressure wave that’s detected by an array of sensors to pinpoint its location, according to Seno Medical’s website.
Seno Medical raised $14.5 million of a hoped for $21 million, according to the filing.
On June 4-5, DeviceTalks Minnesota is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring.
Join leaders from 3M, Abbott, Bigfoot Biomedical, Boston Scientific, Cardionomic, CMF Solutions, Cyient, Google Mayo Clinic, Medical Alley, Medtronic, NxThera, Opus College, Relievant Medsystems, University of Minnesota, Star Tribune, Smith & Nephew, Spry Health, Zimmer Biomet and many more when you register today.
Use the code "DTWeb" to save 15% on the cost of registration.